×
About 17,858 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  6,591 results

Acute Myeloid Leukaemia following Direct Acting Antiviral drugs in HCV-infected patient...
https://doi.org/10.1016/j.clinre.2022.102000
Clinics and Research in Hepatology and Gastroenterology; Carole S, Elena L et. al.

Aug 7th, 2022 - After several cases of peculiar hematological malignancies following introduction of new oral anti-hepatitis C virus (HCV) treatments in our recent practice, we aimed to systematically identify all cases of hematological malignancies (HM) in patie...

Improving Liver Transplant Outcomes for Hepatitis C Virus Hepatocellular Carcinoma in t...
https://doi.org/10.1016/j.transproceed.2022.03.070
Transplantation Proceedings; Okumura K, Sogawa H et. al.

Aug 7th, 2022 - Direct-acting antiviral (DAA) therapy has transformed the outcomes of liver transplant (LT) with hepatitis C virus (HCV). This study aimed to analyze the effects of DAA treatment for HCV-associated hepatocellular carcinoma (HCC) in LT. We included...

Evaluating the Impact of an Educational Intervention on Hepatitis C Screening in a Midw...
https://doi.org/10.1177/10783903221115741
Journal of the American Psychiatric Nurses Association; Northrup AD, Gignac CR et. al.

Aug 7th, 2022 - Affecting more than 3.9 million Americans, the hepatitis C virus (HCV) attacks the liver by causing inflammation. Left untreated, HCV can lead to serious consequences. Targeting high-risk individuals in the inpatient psychiatric setting can lead t...

High Satisfaction with Patient-Centered Telemedicine for Hepatitis C Virus Delivered to...
https://doi.org/10.1089/tmj.2022.0189
Telemedicine Journal and E-health : the Official Journal ... Talal AH, Sofikitou EM et. al.

Aug 5th, 2022 - Background: While telemedicine may increase health care access for vulnerable populations, data are limited on whether people with opioid use disorder (PWOUD) are satisfied with telemedicine. We assessed PWOUD satisfaction with telemedicine and id...

Assessment of Tennessee's county-level vulnerability to hepatitis C virus and HIV outbr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352017
PloS One; Vakili J, Sizemore L et. al.

Aug 5th, 2022 - Human immunodeficiency virus (HIV), hepatitis C virus (HCV), and injection drug use are syndemic in the central Appalachian states. In Tennessee (TN), declines in HIV among persons who inject drugs (PWID) stalled, and HCV infection rates increased...

see more →

Guidelines  14 results

Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus.
https://doi.org/10.1016/j.clinre.2021.101771
Clinics and Research in Hepatology and Gastroenterology; Tran A, Shili-Masmoudi S et. al.

Aug 1st, 2021 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Clinical care for patients with HCV-related liver disease has advanced considerably with developments in screening, diagnostic procedures to evaluate liver fibrosis and i...

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 22nd, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Serv...
https://doi.org/10.1001/jama.2020.1123
JAMA , Owens DK et. al.

Mar 3rd, 2020 - Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, in...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 24th, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

Management of hepatitis C virus infection in patients with chronic kidney disease: posi...
https://doi.org/10.1007/s40620-018-0523-1
Journal of Nephrology; Minutolo R, Aghemo A et. al.

Sep 27th, 2018 - Hepatitis C virus (HCV) infection is now considered a systemic disease due to the occurrence of extra-hepatic manifestations. Among these, the renal involvement is frequent. HCV infection, in fact, is strongly associated with proteinuria and chron...

see more →

Drugs  18 results see all →

News  520 results

Protease Inhibitor–Based DAAs Appear Safe in Decompensated Patients
https://www.medscape.com/viewarticle/974504

May 24th, 2022 - SAN DIEGO – An analysis of a large, international cohort suggests that treatment with protease-inhibitor (PI)–based direct-acting antivirals (DAAs) may be safe for patients with hepatitis C virus (HCV) with cirrhosis and early-stage liver decompen...

DOJ Complaint Flags HCV Drug Denials for People With Addiction
https://www.medscape.com/viewarticle/973791

May 11th, 2022 - A complaint filed with the US Department of Justice (DOJ) alleges that Alabama's Medicaid program is illegally denying curative drug treatment for hepatitis C virus (HCV) infection to people with substance use disorder. The complaint was filed May...

To Engage Injection Drug Users in HCV Care, Go to Where They Are
https://www.medscape.com/viewarticle/970439

Mar 17th, 2022 - For injection drug users with hepatitis C virus (HCV) infection, providing treatment opportunities within a local needle exchange program can provide care to more patients and eventually cure more patients, a new study suggests. The study's findin...

HCV Screening in Pregnancy: Reducing the Risk for Casualties in the Quest for Elimination
https://www.medscape.com/viewarticle/963059

Nov 22nd, 2021 - Because hepatitis C virus (HCV) infection is typically asymptomatic, its presence can easily be overlooked without appropriate screening efforts. For those screening efforts to be effective, they must keep pace with the changing demographic face o...

Liver Cancer Risk Lingers Even After HCV Eradication
https://www.medscape.com/viewarticle/963101

Nov 17th, 2021 - Although the risk for liver cancer diminishes for patients with hepatitis C virus (HCV) infections for whom virus is eliminated with direct-acting antiviral (DAA) drugs, these patients are not out of the woods, and those who do not have a sustaine...

see more →